News
Current chemotherapy for lung cancer achieved limited efficacy due to poor tumor targeting and tissue penetration. Another obstacle in the therapy is activated nuclear factor-κB (NF-κB) in tumor cells ...
Scientists uncover surprising immune response that helps tumors grow, revealing new strategies to improve treatment ...
Nature Medicine - Interleukin-4 receptor-directed cytotoxin therapy of AIDS-associated Kaposi's sarcoma tumors in xenograft model Skip to main content Thank you for visiting nature.com.
Overcoming resistance to chemotherapy is a major and unmet medical challenge in the treatment of pancreatic cancer. Poor drug delivery due to stromal barriers in the tumor microenvironment and ...
Chimeric antigen receptor (CAR) -T cell therapy treatment Richter's transformation Shaomei Feng 1 Peihao Zheng 1 Haidi Liu 1 Meiling Sun 1 Yuelu Guo 2 Lixia Ma 2 Rui Liu 2 Zhonghua Fu 2 Fan Yang 2 ...
Methods RNA-based next-generation sequencing was used to analyse the B cell receptor (BCR) repertoire in peripheral blood and synovial tissue samples collected from 24 seropositive patients with RA ...
Background Shorter half-life glucagon-like peptide-1 receptor agonists (GLP-1 RAs) delay gastric emptying (DGE) more than GLP-1 RAs with longer half-lives. DGE is a known risk factor for ...
251490 Introduction: Absorbed radiation doses (Gy) estimated from nuclear medicine images using dosimetry can optimize targeted radionuclide therapy for individual patients. The integration range of ...
Regardless of grade, meningiomas may become refractory, requiring aggressive treatment. When repeated surgery and high-dose radiation are not sufficient to control tumor growth, somatostatin ...
Cellular therapies, including chimeric antigen receptor T-cell therapy and bispecific antibodies (BsAbs), have revolutionized the treatment of various B-cell non-Hodgkin lymphomas. A number of agents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results